Articles

Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group

The Children’s Hospital of Philadelphia, Division of Oncology, Philadelphia, PA, USA
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
The Hospital for Sick Children, Toronto, ON, Canada
University of Southern California, Los Angeles, CA, USA
St. Jude Children's Research Hospital, Memphis, TN, USA
The Children’s Hospital of Philadelphia, Division of Infectious Disease, Philadelphia, PA, USA
Children's Oncology Group, Monrovia, CA, USA
University of Minnesota, Minneapolis, MN, USA
Texas Children’s Hospital, Houston, TX, USA
Nationwide Children's Hospital, Columbus, OH, USA
Mount Sinai Medical Center, New York, NY, USA
Hemaologics Inc., Seattle, WA, USA
Hemaologics Inc., Seattle, WA, USA
Dana Farber Cancer Center, Boston, MA, USA
St. Jude Children's Research Hospital, Memphis, TN, USA
Alfred I. duPont Hospital for Children, Wilmington, DE, USA
Children's Mercy Hospital and Clinics, Kansas City, MO, USA
Vol. 105 No. 7 (2020): July, 2020 https://doi.org/10.3324/haematol.2019.220962